NEU Ann: FDA approval for Angelman IND and Phase 2 trial - 25th Feb 2022, 9:31am

annb0t

annb0t

Top 20
NEU Ann: FDA approval for Angelman IND and Phase 2 trial
Price Sensitive: Y
Date: 25th Feb 2022, 9:31am

>>> Read announcement: Google: NEU Market Announcements
 
FATNANA

FATNANA

Emerged
Fantastic news!
 
You must log in or register to reply here.

Similar threads

annb0t
NEU Ann: FDA approves Daybue - the first treatment for Rett syndrome - 13th Mar 2023, 9:10am
Replies
0
Views
112
annb0t
annb0t
annb0t
NEU Ann: Prader-Willi syndrome IND for NNZ-2591 approved by FDA - 23rd Jan 2023, 9:31am
Replies
0
Views
125
annb0t
annb0t
annb0t
NEU Ann: Rett Syndrome NDA accepted for Priority Review by FDA - 13th Sep 2022, 9:12am
Replies
0
Views
199
annb0t
annb0t
annb0t
NEU Ann: Acadia submits Rett Syndrome New Drug Application to the FDA - 19th Jul 2022, 9:46am
Replies
0
Views
221
annb0t
annb0t
annb0t
NEU Ann: FDA approval for Pitt Hopkins syndrome IND and Phase 2 trial - 25th Mar 2022, 9:54am
Replies
0
Views
181
annb0t
annb0t
Top Bottom